Filter

Refine by date

—

Refine by collections

  • Print
  • Save

Search Results

You are looking at 31 - 40 of 55 items for :

  • Active surveillance x
Clear All
Roberto Negro Division of Endocrinology, V. Fazzi Hospital, Lecce, Italy

Search for other papers by Roberto Negro in
Google Scholar
PubMed Close
,
Laszlo Hegedüs Department of Endocrinology and Metabolism, Odense University Hospital, Odense, Denmark

Search for other papers by Laszlo Hegedüs in
Google Scholar
PubMed Close
,
Roberto Attanasio Endocrine Unit, IRCCS Istituto Galeazzi, Milan, Italy

Search for other papers by Roberto Attanasio in
Google Scholar
PubMed Close
,
Enrico Papini Department of Endocrinology and Metabolism, Ospedale Regina Apostolorum, Rome, Italy

Search for other papers by Enrico Papini in
Google Scholar
PubMed Close
, and
Kristian H. Winther Department of Endocrinology and Metabolism, Odense University Hospital, Odense, Denmark

Search for other papers by Kristian H. Winther in
Google Scholar
PubMed Close

53 “sometimes” (39%), 41 “frequently” (30.1%), and 34 “always” (25%). Se supplementation was recommended by 83 ETA members (61%) as an alternative to surveillance alone in patients with mild ocular involvement and by 61 (44.9%) as a supplement to the

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000494837
Volume/Issue:
Volume 8: Issue 1
Free access
Ian D Hay Department of Medicine 1, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA

Search for other papers by Ian D Hay in
Google Scholar
PubMed Close
,
Suneetha Kaggal Department of Health Sciences Research, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA

Search for other papers by Suneetha Kaggal in
Google Scholar
PubMed Close
, and
Geoffrey B Thompson Department of Surgery, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA

Search for other papers by Geoffrey B Thompson in
Google Scholar
PubMed Close

postoperative years, only 85/1318 (6%) of the BT-alone patients were being actively followed (remaining at risk), as were 89/541 (16%) of the BT+RRA patients, probably consistent with a greater intensity of postoperative tumor surveillance in those patients who

Article Type:
Research Article
Collections:
Thyroid cancer - clinical
DOI:
https://doi.org/10.1530/ETJ-22-0084
Volume/Issue:
Volume 11: Issue 4
Open access
Zoë Y.G.J. van Lierop Department of Neurology, Maastricht University Medical Centre, Maastricht, The Netherlands

Search for other papers by Zoë Y.G.J. van Lierop in
Google Scholar
PubMed Close
,
Sander Jentjens Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands

Search for other papers by Sander Jentjens in
Google Scholar
PubMed Close
,
Monique H.M.E. Anten Department of Neurology, Maastricht University Medical Centre, Maastricht, The Netherlands
Neurofibromatosis Expert Team, Maastricht University Medical Centre, Maastricht, The Netherlands

Search for other papers by Monique H.M.E. Anten in
Google Scholar
PubMed Close
,
Roel Wierts Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands

Search for other papers by Roel Wierts in
Google Scholar
PubMed Close
,
Connie T. Stumpel Neurofibromatosis Expert Team, Maastricht University Medical Centre, Maastricht, The Netherlands
Department of Clinical Genetics, Maastricht University Medical Centre, Maastricht, The Netherlands

Search for other papers by Connie T. Stumpel in
Google Scholar
PubMed Close
,
Bas Havekes Division of Endocrinology, Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands

Search for other papers by Bas Havekes in
Google Scholar
PubMed Close
, and
Marinus J.P.G. van Kroonenburgh Neurofibromatosis Expert Team, Maastricht University Medical Centre, Maastricht, The Netherlands
Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands

Search for other papers by Marinus J.P.G. van Kroonenburgh in
Google Scholar
PubMed Close

primary (autoimmune) thyroid disease, and the numbers lost to follow-up make our conclusions not firm but only indicative. Conclusions In the present form our study did not show an increased risk of thyroid pathology in NF1 patients. Active

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000488706
Volume/Issue:
Volume 7: Issue 3
Open access
Roberto Negro Division of Endocrinology, “V. Fazzi” Hospital, Lecce, Italy

Search for other papers by Roberto Negro in
Google Scholar
PubMed Close
,
Roberto Attanasio Endocrinology Service, Galeazzi Institute IRCCS, Milan, Italy

Search for other papers by Roberto Attanasio in
Google Scholar
PubMed Close
,
Enrico Papini Department of Endocrinology, Regina Apostolorum Hospital, Albano Laziale, Italy

Search for other papers by Enrico Papini in
Google Scholar
PubMed Close
,
Rinaldo Guglielmi Department of Endocrinology, Regina Apostolorum Hospital, Albano Laziale, Italy

Search for other papers by Rinaldo Guglielmi in
Google Scholar
PubMed Close
,
Franco Grimaldi Endocrinology and Metabolic Disease Unit, Azienda Ospedaliero-Universitaria “S. Maria della Misericordia”, Udine, Italy

Search for other papers by Franco Grimaldi in
Google Scholar
PubMed Close
,
Vincenzo Toscano Endocrinology, Department of Clinical and Molecular Medicine, Sant’Andrea Hospital, Sapienza University of Rome, Roma, Italy

Search for other papers by Vincenzo Toscano in
Google Scholar
PubMed Close
,
Dan Alexandru  Niculescu Department of Endocrinology, Carol Davila University of Medicine of Pharmacy, Bucharest, Romania

Search for other papers by Dan Alexandru  Niculescu in
Google Scholar
PubMed Close
,
Diana Loreta  Paun Department of Endocrinology, Carol Davila University of Medicine of Pharmacy, Bucharest, Romania

Search for other papers by Diana Loreta  Paun in
Google Scholar
PubMed Close
, and
Catalina Poiana Department of Endocrinology, Carol Davila University of Medicine of Pharmacy, Bucharest, Romania

Search for other papers by Catalina Poiana in
Google Scholar
PubMed Close

TSH. The active surveillance of TSH during pregnancy is justified by the evidence that about 20% of euthyroid women with TAI show TSH values > 4.0 mIU/L throughout gestation [ 27 , 28 ]. Whether or not LT4 treatment (suggested by about 20% of

Article Type:
Case Report
DOI:
https://doi.org/10.1159/000490944
Volume/Issue:
Volume 7: Issue 6
Free access
Signe Buhl Gram Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark

Search for other papers by Signe Buhl Gram in
Google Scholar
PubMed Close
,
Jacob Høygaard Rasmussen Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark

Search for other papers by Jacob Høygaard Rasmussen in
Google Scholar
PubMed Close
,
Ulla Feldt-Rasmussen Department of Medical Endocrinology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark

Search for other papers by Ulla Feldt-Rasmussen in
Google Scholar
PubMed Close
,
Jens Bentzen Department of Oncology, Herlev Hospital, Copenhagen University, Copenhagen, Denmark

Search for other papers by Jens Bentzen in
Google Scholar
PubMed Close
,
Giedrius Lelkaitis Department of Pathology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark

Search for other papers by Giedrius Lelkaitis in
Google Scholar
PubMed Close
,
Christian von Buchwald Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark

Search for other papers by Christian von Buchwald in
Google Scholar
PubMed Close
, and
Christoffer Holst Hahn Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark

Search for other papers by Christoffer Holst Hahn in
Google Scholar
PubMed Close

thyroid microcarcinoma: time to shift from surgery to active surveillance? Lancet Diabetes Endocrinol . 2016 Nov ; 4 ( 11 ): 933 – 42 . 10.1016/S2213-8587(16)30180-2 27550849 2213-8587 13 Tee YY , Lowe AJ , Brand CA , Judson RT

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000500539
Volume/Issue:
Volume 8: Issue 5
Free access
Stéphane Bardet Department of Nuclear Medicine and Thyroid Unit, Centre François Baclesse, Caen, France

Search for other papers by Stéphane Bardet in
Google Scholar
PubMed Close
,
Renaud Ciappuccini Department of Nuclear Medicine and Thyroid Unit, Centre François Baclesse, Caen, France

Search for other papers by Renaud Ciappuccini in
Google Scholar
PubMed Close
,
Livia Lamartina Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy, Villejuif, France

Search for other papers by Livia Lamartina in
Google Scholar
PubMed Close
, and
Sophie Leboulleux Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy, Villejuif, France

Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed Close

low tumour burden, active surveillance was advised. In June 2017, CT and CEA levels were 1097 ng/L and 9.5 µg/L, respectively, and MRI detected new small pelvic bone lesions, so treatment with denosumab was initiated. The symptoms were slowly but

Article Type:
Case Report
Collections:
Thyroid cancer - clinical
DOI:
https://doi.org/10.1530/ETJ-21-0104
Volume/Issue:
Volume 11: Issue 2
Open access
Camille Buffet Department of Thyroid Pathologies and Endocrine Tumors, AP-HP, Pitié-Salpêtrière Hospital, Groupe de Recherche Clinique n°16 Tumeurs Thyroïdiennes, Sorbonne Université, Paris, France
UMR9019, Genome Integrity and Cancers, CNRS, Villejuif, France

Search for other papers by Camille Buffet in
Google Scholar
PubMed Close
,
Sophie Leboulleux Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy Institut, Villejuif, France

Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed Close
,
Françoise Kraeber-Bodéré Nuclear Medicine Department, Université de Nantes, CHU de Nantes, CNRS, Inserm, CRCINA, Nantes, France
CHU Nantes/ICO, Saint-Herblain, France

Search for other papers by Françoise Kraeber-Bodéré in
Google Scholar
PubMed Close
,
Caroline Bodet-Milin Nuclear Medicine Department, Université de Nantes, CHU de Nantes, CNRS, Inserm, CRCINA, Nantes, France
CHU Nantes/ICO, Saint-Herblain, France

Search for other papers by Caroline Bodet-Milin in
Google Scholar
PubMed Close
,
Laure Cabanes Department of Cardiology, APHP, Cochin Hospital, Paris, France
Université de Paris, Paris, France

Search for other papers by Laure Cabanes in
Google Scholar
PubMed Close
,
Anthony Dohan Radiology Department, Université de Paris, Paris, France
Department of Radiology, AP-HP, Hôpital Cochin, Paris, France

Search for other papers by Anthony Dohan in
Google Scholar
PubMed Close
,
Pascal Leprince Department of Thoracic and Cardiovascular Surgery, Sorbonne Université, AP-HP, Pitié-Salpêtrière Hospital, Paris, France

Search for other papers by Pascal Leprince in
Google Scholar
PubMed Close
,
Martin Schlumberger UMR9019, Genome Integrity and Cancers, CNRS, Villejuif, France
Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy Institute, Villejuif, France

Search for other papers by Martin Schlumberger in
Google Scholar
PubMed Close
,
Olivier Huillard Université de Paris, Sorbonne Paris Cité, Paris, France
Department of Medical Oncology, AP-HP, Hôpital Cochin, Paris, France

Search for other papers by Olivier Huillard in
Google Scholar
PubMed Close
, and
Lionel Groussin INSERM Unité 1016, CNRS UMR 8104, Institut Cochin, Paris, France
Université de Paris, Paris, France
Department of Endocrinology, AP-HP, Hôpital Cochin, Paris, France

Search for other papers by Lionel Groussin in
Google Scholar
PubMed Close

active surveillance was chosen. Unfortunately, 1 year later, new hepatic and brain metastases (right 25-mm frontal-parietal and left occipital lesions of few millimeters) were diagnosed in the workup of myoclonic seizures of the left hand. This diagnosis

Article Type:
Case Report
DOI:
https://doi.org/10.1159/000517716
Volume/Issue:
Volume 10: Issue 6
Open access
Esther J. van Zuuren Departments of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands

Search for other papers by Esther J. van Zuuren in
Google Scholar
PubMed Close
,
Amira Y. Albusta College of Medicine, AMA International University of Bahrain, Manama

Search for other papers by Amira Y. Albusta in
Google Scholar
PubMed Close
,
Zbys Fedorowicz UKCC (Bahrain Branch), The Cochrane Collaboration, Awali, Bahrain

Search for other papers by Zbys Fedorowicz in
Google Scholar
PubMed Close
,
Ben Carter Institute of Primary Care & Public Health, Cardiff University School of Medicine, Cardiff, UK

Search for other papers by Ben Carter in
Google Scholar
PubMed Close
, and
Hanno Pijl Departments of Endocrinology, Leiden University Medical Centre, Leiden, The Netherlands

Search for other papers by Hanno Pijl in
Google Scholar
PubMed Close

thyroglobulin to produce thyroid hormone. The active form of thyroid hormone, tri-iodothyronine (T3), is produced by de-iodination of the prohormone T4 by type I and type II iodothyronine de-iodinasesin, a two-substrate ‘ping-pong' mechanism of reaction, along

Article Type:
Systematic Review
DOI:
https://doi.org/10.1159/000356040
Volume/Issue:
Volume 3: Issue 1
Free access
Kris Poppe Endocrine Unit, Department of Internal Medicine, University Hospital UZ Brussel (VUB), Brussels, Belgium

Search for other papers by Kris Poppe in
Google Scholar
PubMed Close
,
Alicja Hubalewska-Dydejczyk Department of Endocrinology, Jagiellonian University Medical College, Kraków, Poland

Search for other papers by Alicja Hubalewska-Dydejczyk in
Google Scholar
PubMed Close
,
Peter Laurberg Department of Endocrinology and Medicine, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark

Search for other papers by Peter Laurberg in
Google Scholar
PubMed Close
,
Roberto Negro Division of Endocrinology, V. Fazzi Hospital, Lecce

Search for other papers by Roberto Negro in
Google Scholar
PubMed Close
,
Francesco Vermiglio Cattedra di Endocrinologia, Policlinico Universitario, Messina, Italy

Search for other papers by Francesco Vermiglio in
Google Scholar
PubMed Close
, and
Bijay Vaidya Department of Endocrinology, Royal Devon & Exeter Hospital, Exeter, UK

Search for other papers by Bijay Vaidya in
Google Scholar
PubMed Close

responders would never measure TRAb during the pregnancy compared to 11% in women with actively treated GD; p = 0.026 (table 4 ). Table 4 Responders’ recommendations for the measurement of TRAb during pregnancy in a woman with GD on ATDs and in a

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000336101
Volume/Issue:
Volume 1: Issue 1
Free access
Roberto Fiore Division of Endocrinology, Diabetes and Metabolism, University Hospital of Lausanne and University of Lausanne, Hôtel des Patients, Lausanne, Switzerland

Search for other papers by Roberto Fiore in
Google Scholar
PubMed Close
,
Stefano La Rosa Unit of Pathology, Department of Medicine and Surgery, University of Insubria, Varese, Italy

Search for other papers by Stefano La Rosa in
Google Scholar
PubMed Close
,
Silvia Uccella Unit of Pathology, Department of Medicine and Surgery, University of Insubria, Varese, Italy

Search for other papers by Silvia Uccella in
Google Scholar
PubMed Close
,
Deborah Marchiori Unit of Pathology, Department of Medicine and Surgery, University of Insubria, Varese, Italy

Search for other papers by Deborah Marchiori in
Google Scholar
PubMed Close
, and
Peter A Kopp Division of Endocrinology, Diabetes and Metabolism, University Hospital of Lausanne and University of Lausanne, Hôtel des Patients, Lausanne, Switzerland

Search for other papers by Peter A Kopp in
Google Scholar
PubMed Close

thyroxine (T4). Deiodination of the outer ring generates the active thyroid hormone triiodothyronine (T3), whereas that of the inner ring converts T4 to reverse T3 (rT3), and T3 to 3,3’-diiodo- l -thyronine (T2), which are both biologically inactive

Article Type:
Case Report
Collections:
Hypothyroidism
DOI:
https://doi.org/10.1530/ETJ-22-0006
Volume/Issue:
Volume 11: Issue 5
Open access